Ignite Creation Date:
2024-05-06 @ 4:06 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04878627
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-05
First Post:
2021-04-26
Brief Title:
Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa
Sponsor:
University of California San Diego
Organization:
University of California San Diego
Study Overview
Official Title:
The Role of Cannabidiol in Regulating Meal Time Anxiety in Anorexia Nervous Safety Tolerability and Pharmacokinetics
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
No studies of cannabidiol CBD have focused on Anorexia Nervosa AN Dose side effects tolerability acceptability of pure CBD in AN must be established The current study is an important first step in the investigation of CBD for AN Cannabis products have been recently legalized in many states and CBD in particular has been shown to reduce anxiety Therefore CBD may represent a promising new treatment for AN The endocannabinoid system is involved in the regulation of functions relevant to eating disorders Furthermore data suggest that eating disorders are associated with alterations of the endocannabinoid system Prior attempts to target the endocannabinoid system in AN have focused on CB1 receptor agonists that can increase anxiety Moreover CBD may be particularly beneficial in decreasing anxiety in AN via its action at serotonin receptors Lastly the impact of CBD on eating behavior and weight in AN must be determined The current study seeks to explore these hypotheses using the aims in the following section
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None